Resources
The Cost of Silence: Why Early Detection is the Only Way to Stop Ebola
Every delayed outbreak response is a predictable failure. With the right tools deployed in advance, we can break the cycle for good.
⚠ Current DRC Outbreak (Bundibugyo, detected 24 April): 341 confirmed 62 fatalities · ~$1 billion committed in emergency funding cases ·
A Cycle of Tragedy We Keep Repeating
The history of viral hemorrhagic fevers is a cycle of tragedy we seem destined to repeat. First discovered in 1976, the Ebolavirus has since caused over 40 documented outbreaks, while its even deadlier cousin, the Marburg virus (identified in 1967), has triggered at least 15. While their natural reservoir remains unconfirmed, evidence points to African fruit bats.
The “Delayed” Trap
These viruses are endemic to Sub-Saharan Africa — often emerging in remote, war-torn rainforest regions where access is notoriously difficult. The DRC has recorded the highest frequency of Ebola cases; Angola has suffered the largest and deadliest Marburg outbreaks. We know these diseases exist. We know they are devastating. We know they will strike again. Yet every time, we react as if it is a surprise. “Delayed detection” is the common denominator in every failure, followed swiftly by “delayed response” and “delayed release of critical resources”. The word delayed is thrown around like a tennis ball at Wimbledon — but the reality is far from a game.The Exponential Power of Early Detection
Ironically, the first lever we need to pull — detection — is also the most inexpensive. Early detection is both life-saving and resource-saving; it triggers an exponential butterfly effect downstream.
To put the cost of failure into perspective: nearly $1 billion has already been committed to the current outbreak — from the World Bank, the US CDC, The Pandemic Fund, the Gates Foundation, and the Africa CDC.
“Nearly $1 billion has been committed to the current outbreak. Forward planning costs a fraction of a delayed response.”
Detect. Contain. Treat.
We must shift from reactive to proactive. Investing in early, accurate diagnostic tools and deploying them through rapid response teams — much like modern military rapid reaction forces — is an absolute no-brainer.
The Right Tool for the Job
It is high time we equipped ourselves with a pan-detection molecular test capable of identifying all known Ebolavirus and Marburgvirus species. This is entirely achievable — there are only six known species of Ebolavirus and one of Marburgvirus.
EMPE Diagnostics is ready to lead this charge. Our Pli-RCA technology — which harnesses the diagnostic power of Rolling Circle Amplification — is uniquely positioned to address this need. Our versatile, accurate chemistry provides highly precise results for a large number of targets in a single reaction on any open qPCR platform.
In an outbreak, rapid mass testing in hotspot areas is the most critical tool for containment. Combatting these deadly, resource-intensive outbreaks requires keeping tens of thousands of tests in stock, ready for deployment at a moment’s notice. This demands forward planning, yet it requires only a fraction of the funding currently swallowed by the costs of a delayed response.
The cost of inaction is too high. It is time to invest in early detection. → Learn more at empe-diagnostics.com
Ebola early detection
Ebola early detection
Ebola early detection
Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
molecular Ebola detection
molecular Ebola detection
molecular Ebola detection
Ebolavirus diagnosis
Ebolavirus diagnosis